agilon health, inc. (NYSE:AGL) Receives $4.03 Consensus Target Price from Analysts

agilon health, inc. (NYSE:AGL) has been assigned an average recommendation of “Hold” from the eighteen ratings firms that are presently covering the firm, MarketBeat.com reports. Two investment analysts have rated the stock with a sell rating, fourteen have given a hold rating and two have issued a buy rating on the company. The average twelve-month price target among brokerages that have updated their coverage on the stock in the last year is $4.03.

AGL has been the subject of several research reports. Bank of America cut agilon health from a “buy” rating to an “underperform” rating and set a $3.00 target price for the company. in a report on Wednesday, October 2nd. Sanford C. Bernstein increased their price objective on shares of agilon health from $2.50 to $3.15 and gave the company a “market perform” rating in a research note on Wednesday, January 15th. Stifel Nicolaus dropped their target price on agilon health from $7.00 to $2.00 and set a “hold” rating on the stock in a research report on Tuesday, November 12th. Barclays decreased their price objective on agilon health from $5.00 to $2.00 and set an “underweight” rating for the company in a research note on Monday, November 11th. Finally, JMP Securities lowered agilon health from an “outperform” rating to a “market perform” rating in a research note on Monday, November 11th.

Insider Activity at agilon health

In other agilon health news, Director Karen Mcloughlin acquired 25,000 shares of the business’s stock in a transaction that occurred on Friday, December 13th. The stock was purchased at an average cost of $2.20 per share, with a total value of $55,000.00. Following the transaction, the director now owns 73,166 shares of the company’s stock, valued at $160,965.20. This trade represents a 51.90 % increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director John William Wulf purchased 45,000 shares of agilon health stock in a transaction dated Thursday, December 5th. The stock was bought at an average cost of $2.18 per share, for a total transaction of $98,100.00. Following the completion of the purchase, the director now directly owns 206,133 shares in the company, valued at approximately $449,369.94. This trade represents a 27.93 % increase in their position. The disclosure for this purchase can be found here. In the last ninety days, insiders bought 90,000 shares of company stock valued at $198,100. 3.20% of the stock is owned by insiders.

Institutional Investors Weigh In On agilon health

Several large investors have recently added to or reduced their stakes in AGL. Point72 Asia Singapore Pte. Ltd. acquired a new position in shares of agilon health during the third quarter worth $28,000. Oak Thistle LLC purchased a new position in shares of agilon health in the 4th quarter valued at about $25,000. City State Bank acquired a new stake in shares of agilon health during the 3rd quarter worth about $52,000. Quarry LP lifted its stake in agilon health by 500.3% during the second quarter. Quarry LP now owns 18,254 shares of the company’s stock worth $119,000 after purchasing an additional 15,213 shares during the last quarter. Finally, Aigen Investment Management LP purchased a new position in agilon health in the third quarter valued at approximately $79,000.

agilon health Price Performance

AGL stock opened at $3.69 on Friday. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.06. The stock has a market cap of $1.52 billion, a PE ratio of -3.92 and a beta of 0.53. agilon health has a 12 month low of $1.50 and a 12 month high of $7.73. The company has a 50-day moving average price of $2.22 and a 200 day moving average price of $3.58.

agilon health (NYSE:AGL) last posted its quarterly earnings results on Thursday, November 7th. The company reported ($0.29) EPS for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.19). The company had revenue of $1.45 billion during the quarter, compared to the consensus estimate of $1.47 billion. agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. During the same quarter in the previous year, the company posted ($0.06) earnings per share. Equities research analysts anticipate that agilon health will post -0.59 earnings per share for the current year.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.